Interactive Working Group Roundtable Session – Meeting Rising Demand with Collective Approaches to Increase Manufacturing Capacity in Microbiome Drug Development
Time: 10:30 am
day: Day Two Track B (AM)
Details:
Join this interactive working session designed to bring perspectives from biopharma and CMOs to light, on today’s state of play for microbiome drug manufacture capacity. Facing capacity challenges for developers looking to up-scale, this session brings all the opportunity to discuss current strategies in the short and long-term to navigate the current manufacture landscape.
Hear and contribute actionable takeaways in a room of influential leaders in the microbiome drug development sphere to address:
- How can a better understanding of the manufacture capacity landscape support industryforward planning and scale-up speed?
- How can industry better adopt automation, process optimization, and novel manufacturing technologies to meet the rising demand for microbiome-based therapeutic interventions?
- What risk, resource optimization and scalability considerations will be crucial in the coming 12 months to support resilient and responsive approaches to manufacture capacity requirements?
